Invention Grant
- Patent Title: Bispecific antagonist comprising a LAG-3 binding domain
-
Application No.: US16795804Application Date: 2020-02-20
-
Publication No.: US11667716B2Publication Date: 2023-06-06
- Inventor: Jackie Sheng , Margaret Karow , Wei Zhang
- Applicant: GENSUN BIOPHARMA, INC.
- Applicant Address: US CA Newbury Park
- Assignee: Gensun Biopharma, Inc.
- Current Assignee: Gensun Biopharma, Inc.
- Current Assignee Address: US CA Newbury Park
- Agency: Rimon Law
- Agent Michael Ye
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00 ; A61P35/00 ; C07K16/22 ; C07K14/00 ; C07K14/71 ; C07K16/46
Abstract:
Antitumor antagonists that bind specifically to immune checkpoint regulator are disclosed. Also disclosed is a method of treating proliferative disorders with the antitumor antagonists.
Public/Granted literature
- US20200181272A1 ANTITUMOR IMMUNE CHECKPOINT REGULATOR ANTAGONISTS Public/Granted day:2020-06-11
Information query
